ReNetX Bio, Inc.
Biotechnology company · New Haven, Connecticut, United States
ReNetX Bio, Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2009. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.3 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $2.8 million sold in a notice filed in 2020.
ReNetX Bio at a glance
What does ReNetX Bio do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.3 million in total (2013 to 2020). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $2.8 million sold (2020).
Frequently asked questions about ReNetX Bio
Where is ReNetX Bio headquartered?
ReNetX Bio, Inc. is headquartered in New Haven, Connecticut, United States.
What does ReNetX Bio do?
ReNetX Bio, Inc. is a biotechnology company.
When was ReNetX Bio founded?
The earliest incorporation on record for ReNetX Bio, Inc. is in 2009, according to public company registers.
Similar companies
- Allyx Therapeutics, Inc.New Haven, Connecticut, United States
- Invivyd, Inc.New Haven, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.